ifosfamide has been researched along with Nervous System Disorders in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have recently treated 66 women with breast cancer with escalating doses of ifosfamide, carboplatin, and etoposide (ICE) followed by autologous stem cell rescue (ASCR)." | 9.07 | Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients. ( Elfenbein, GJ; Fields, KK; Hiemenz, JW; Janssen, WE; Kronish, LE; Machak, MC; Perkins, JP; Zorsky, PE, 1993) |
| "The Gastrointestinal Tumor Study Group (GITSG) investigated the efficacy of ifosfamide with mesna uroprotection in 30 patients with advanced inoperable pancreatic carcinoma that was confirmed histologically." | 7.67 | Ifosfamide is an inactive substance in the treatment of pancreatic carcinoma. The Gastrointestinal Tumor Study Group. ( , 1989) |
| "Ifosfamide is one of the most efficient antimitotic in soft tissue sarcoma." | 5.08 | [High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients]. ( Baranzelli, MC; Deligny, N; Demaille, MC; Gourmel, B; N'Guyen, M; Pichon, F, 1997) |
| "We have recently treated 66 women with breast cancer with escalating doses of ifosfamide, carboplatin, and etoposide (ICE) followed by autologous stem cell rescue (ASCR)." | 5.07 | Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients. ( Elfenbein, GJ; Fields, KK; Hiemenz, JW; Janssen, WE; Kronish, LE; Machak, MC; Perkins, JP; Zorsky, PE, 1993) |
| "In summary, female sex, low total bilirubin, albumin and haemoglobin levels, and obesity appear to be associated with ifosfamide-induced encephalopathy." | 4.84 | Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature. ( Beri, R; Shord, SS; Sweiss, KI, 2008) |
| "The Gastrointestinal Tumor Study Group (GITSG) investigated the efficacy of ifosfamide with mesna uroprotection in 30 patients with advanced inoperable pancreatic carcinoma that was confirmed histologically." | 3.67 | Ifosfamide is an inactive substance in the treatment of pancreatic carcinoma. The Gastrointestinal Tumor Study Group. ( , 1989) |
| "Ifosfamide was given to 61 patients with malignant solid tumors diagnosed before the age of 21 years." | 1.27 | Phase II trial of ifosfamide in children with malignant solid tumors. ( Douglass, EC; Etcubanas, E; Green, AA; Hayes, FA; Horowitz, ME; Meyer, WH; Pratt, CB; Thompson, EI; Wilimas, JA, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hancock, SB | 1 |
| Krempl, GA | 1 |
| Canfield, V | 1 |
| Bogardus, C | 1 |
| Kojouri, K | 1 |
| Kaneaster, SK | 1 |
| Medina, JE | 1 |
| Sweiss, KI | 1 |
| Beri, R | 1 |
| Shord, SS | 1 |
| Loehrer, PJ | 1 |
| Williams, SD | 1 |
| Einhorn, LH | 1 |
| Fields, KK | 1 |
| Perkins, JP | 1 |
| Hiemenz, JW | 1 |
| Zorsky, PE | 1 |
| Janssen, WE | 1 |
| Kronish, LE | 1 |
| Machak, MC | 1 |
| Elfenbein, GJ | 1 |
| Baranzelli, MC | 1 |
| Pichon, F | 1 |
| Gourmel, B | 1 |
| N'Guyen, M | 1 |
| Deligny, N | 1 |
| Demaille, MC | 1 |
| Kosmas, C | 1 |
| Tsavaris, NB | 1 |
| Polyzos, A | 1 |
| Malamos, NA | 1 |
| Katsikas, M | 1 |
| Antonopoulos, MJ | 1 |
| Noël, G | 1 |
| Mazeron, JJ | 1 |
| Hannigan, EV | 1 |
| Dinh, TV | 1 |
| Doherty, MG | 1 |
| Elias, AD | 1 |
| Ayash, LJ | 1 |
| Eder, JP | 1 |
| Wheeler, C | 1 |
| Deary, J | 1 |
| Weissman, L | 1 |
| Schryber, S | 1 |
| Hunt, M | 1 |
| Critchlow, J | 1 |
| Schnipper, L | 1 |
| Pratt, CB | 3 |
| Goren, MP | 2 |
| Meyer, WH | 2 |
| Singh, B | 1 |
| Dodge, RK | 1 |
| Wright, RK | 1 |
| Pell, FE | 1 |
| Horowitz, ME | 1 |
| Etcubanas, E | 1 |
| Thompson, EI | 1 |
| Douglass, EC | 1 |
| Wilimas, JA | 1 |
| Hayes, FA | 1 |
| Green, AA | 1 |
1 review available for ifosfamide and Nervous System Disorders
| Article | Year |
|---|---|
Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Topics: Adult; Albumins; Antineoplastic Agents, Alkylating; Bilirubin; Brain Diseases; Cohort Studies; Enzym | 2008 |
5 trials available for ifosfamide and Nervous System Disorders
| Article | Year |
|---|---|
Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di | 2008 |
Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1993 |
[High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients].
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Clonazepam; Dose-Response Relations | 1997 |
Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, | 2000 |
A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Com | 1991 |
7 other studies available for ifosfamide and Nervous System Disorders
| Article | Year |
|---|---|
N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
Topics: Acetylcysteine; Adenocarcinoma; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combin | 1983 |
[Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; | 2001 |
Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Drug Therapy, Combination; Female; Hematolog | 1991 |
Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors.
Topics: Adolescent; Adult; Child; Cisplatin; Humans; Ifosfamide; Neoplasms; Nervous System Diseases; Risk | 1990 |
Ifosfamide is an inactive substance in the treatment of pancreatic carcinoma. The Gastrointestinal Tumor Study Group.
Topics: Adult; Aged; Carcinoma; Drug Evaluation; Female; Hematuria; Humans; Ifosfamide; Male; Mesna; Nervous | 1989 |
Dechloroethylation of ifosfamide and neurotoxicity.
Topics: Acetaldehyde; Humans; Ifosfamide; Nervous System Diseases | 1986 |
Phase II trial of ifosfamide in children with malignant solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Eva | 1987 |